Response evaluation: beyond RECIST

被引：23

作者：

Eisenhauer, E. A. ^{[1
]}

机构：

[1] Queens Univ, NCIC Clin Trials Grp, Kingston, ON K7L 3N6, Canada

来源：

ANNALS OF ONCOLOGY | 2007年 / 18卷

关键词：

D O I：

10.1093/annonc/mdm290

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

收藏

页码：29 / 32

页数：4

相关论文

共 18 条

[1]

ANALYZING THE SAME DATA IN 2 WAYS - A DEMONSTRATION MODEL TO ILLUSTRATE THE REPORTING AND MISREPORTING OF CLINICAL-TRIALS [J].

BAAR, J ;

TANNOCK, I .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (07) :969-978

[2]

Phase I and II trials of novel anti-cancer agents: Endpoints, efficacy and existentialism - The Michel Clavel lecture, held at the 10th NCI-EORTC Conference on New Drugs in Cancer Therapy, Amsterdam, 16-19 June 1998 [J].

Eisenhauer, EA .

ANNALS OF ONCOLOGY, 1998, 9 (10) :1047-1052

[3]

Anticancer agents targeting signaling molecules and cancer cell environment: Challenges for drug development? [J].

Gelmon, KA ;

Eisenhauer, EA ;

Harris, AL ;

Ratain, MJ ;

Workman, P .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (15) :1281-1287

[4]

Objective responses in patients with malignant melanoma or renal cell cancer in early clinical studies do not predict regulatory approval [J].

Goffin, J ;

Baral, S ;

Tu, DS ;

Nomikos, D ;

Seymour, L .

CLINICAL CANCER RESEARCH, 2005, 11 (16) :5928-5934

[5]

Measures of response: RECIST, WHO, and new alternatives [J].

Jaffe, C. Carl .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (20) :3245-3251

[6]

RANDOMIZED DISCONTINUATION TRIALS - UTILITY AND EFFICIENCY [J].

KOPEC, JA ;

ABRAHAMOWICZ, M ;

ESDAILE, JM .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (09) :959-971

[7]

Clinical trial designs for cytostatic agents: Are new approaches needed? [J].

Korn, EL ;

Arbuck, SG ;

Pluda, JM ;

Simon, R ;

Kaplan, RS ;

Christian, MC .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) :265-272

[8]

Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials [J].

Leach, MO ;

Brindle, KM ;

Evelhoch, JL ;

Griffiths, JR ;

Horsman, MR ;

Jackson, A ;

Jayson, G ;

Judson, IR ;

Knopp, MV ;

Maxwell, RJ ;

McIntyre, D ;

Padhani, AR ;

Price, P ;

Rathbone, R ;

Rustin, G ;

Tofts, PS ;

Tozer, GM ;

Vennart, W ;

Waterton, JC ;

Williams, SR ;

Workman, P .

BRITISH JOURNAL OF RADIOLOGY, 2003, 76 :S87-S91

[9]

A theoretical approach to choosing the minimum number of multiple tumors required for assessing treatment response [J].

Mazumdar, M ;

Smith, A ;

Debroy, PP ;

Schwartz, LH .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2005, 58 (02) :150-153

[10]

MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO